Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UroCor was a specialized healthcare company focused on providing comprehensive diagnostic and therapeutic management services for urologists and their patients. The company operated a high-complexity clinical laboratory specializing in urological pathology and offered a range of diagnostic tests for prostate cancer, bladder cancer, and other urological conditions. UroCor was known for its proprietary database and diagnostic tools that helped physicians manage patient care more effectively through integrated clinical data. Their product line included the StoneRisk profile for kidney stone management and advanced biopsy analysis services. Headquartered in Oklahoma City, the company was a leader in the niche urology diagnostics market during the 1990s and early 2000s. UroCor was acquired by Dianon Systems in 2002 for approximately $180 million, which was subsequently acquired by LabCorp in 2003.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UroCor.